TGF-β autocrine pathway and MAPK signaling promote cell invasiveness and in vivo mammary adenocarcinoma tumor progression | ||
| dc.conicet.organizacion | Montefiore Medical Center | |
| dc.conicet.organizacion | Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo" | |
| dc.conicet.organizacion | Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo" | |
| dc.conicet.organizacion | Roswell Park Cancer Institute | |
| dc.conicet.organizacion | Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo" | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas | |
| dc.contributor.author | Daroqui, María Cecilia | |
| dc.contributor.author | Vazquez, Paula | |
| dc.contributor.author | Bal De Kier Joffé, Elisa | |
| dc.contributor.author | Bakin, Andrei V. | |
| dc.contributor.author | Puricelli, Lydia Ines | |
| dc.date.issued | 2012-08 | |
| dc.description.abstract | Breast cancer progression and metastasis have been linked to abnormal signaling by transforming growth factor-β (TGF-β) cytokines. In early-stage breast cancers, TGF-β exhibits tumor suppressor activity by repressing cell proliferation and inducing cell death, whereas in advanced-stage tumors, TGF-β promotes invasion and metastatic dissemination. The molecular mechanisms underlying pro-oncogenic activities of TGF-β are not fully understood. The present study validates the role of TGF-β signaling in cancer progression and explores mediators of pro-oncogenic TGF-β activities using the LM3 mammary adenocarcinoma cell line, derived from a spontaneous murine mammary adenocarcinoma. Expression of kinase-inactive TGF-β receptors decreased both basal and TGF-β-induced invasion. Analysis of signal transduction mediators showed that p38MAPK and MEK contribute to TGF-β stimulation of cell motility and invasion. TGF-β disrupted the epithelial actin structures supporting cell-cell adhesions, and increased linear actin filaments. Moreover, MEK and p38MAPK pathways showed opposite effects on actin remodeling in response to TGF-β. Blockade of Raf-MEK signaling enhanced TGF-β induction of actin stress-fibers whereas p38MAPK inhibitors blocked this effect. A novel observation was made that TGF-β rapidly activates the actin nucleation Arp2/3 complex. In addition, TGF-β stimulated matrix metalloproteinase MMP-9 secretion via a MAPK-independent pathway. Experiments using syngeneic mice showed that kinase-inactive TGF-β receptors inhibit the first stages of LM3 tumor growth in vivo. Our studies demonstrate that autocrine TGF-β signaling contributes to the invasive behavior of mammary carcinoma cells. Moreover, we show that both MAPK-dependent and -independent pathways are necessary for TGF-β-induced effects. Therefore, MEK-ERK and p38 MAPK pathways are potential venues for therapeutic intervention in pro-oncogenic TGF-β signaling. | es |
| dc.description.fil | Fil: Daroqui, María Cecilia. Montefiore Medical Center; Estados Unidos | |
| dc.description.fil | Fil: Vazquez, Paula. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; Argentina | |
| dc.description.fil | Fil: Bal De Kier Joffé, Elisa. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; Argentina | |
| dc.description.fil | Fil: Bakin, Andrei V.. Roswell Park Cancer Institute; Estados Unidos | |
| dc.description.fil | Fil: Puricelli, Lydia Ines. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina | |
| dc.format | application/pdf | es |
| dc.identifier.citation | Daroqui, María Cecilia; Vazquez, Paula; Bal De Kier Joffé, Elisa; Bakin, Andrei V.; Puricelli, Lydia Ines; TGF-β autocrine pathway and MAPK signaling promote cell invasiveness and in vivo mammary adenocarcinoma tumor progression; Spandidos Publications; Oncology Reports; 28; 2; 8-2012; 567-575 | es |
| dc.identifier.institucional | CONICET | |
| dc.identifier.issn | 1021-335X | es |
| dc.identifier.repo | CONICET Digital | |
| dc.identifier.uri | http://hdl.handle.net/11336/217957 | |
| dc.journal.ciudad | Atenas | es |
| dc.journal.number | 2 | es |
| dc.journal.pagination | 567-575 | es |
| dc.journal.pais | Grecia | es |
| dc.journal.title | Oncology Reports | es |
| dc.journal.volume | 28 | es |
| dc.language.iso | eng | es |
| dc.publisher | Spandidos Publications | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/https://www.spandidos-publications.com/10.3892/or.2012.1813 | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/doi/https://doi.org/10.3892/or.2012.1813 | |
| dc.rights | info:eu-repo/semantics/openAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ | * |
| dc.subject | ACTIN CYTOSKELETON | es |
| dc.subject | INVASION | es |
| dc.subject | MAMMARY ADENOCARCINOMA | es |
| dc.subject | MATRIX METALLOPROTEINASE-9 | es |
| dc.subject | MIGRATION | es |
| dc.subject | TRANSFORMING GROWTH FACTOR-Β | es |
| dc.subject.classification | Otras Ciencias de la Salud | es |
| dc.subject.classification | Ciencias de la Salud | es |
| dc.subject.classification | CIENCIAS MÉDICAS Y DE LA SALUD | es |
| dc.title | TGF-β autocrine pathway and MAPK signaling promote cell invasiveness and in vivo mammary adenocarcinoma tumor progression | es |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.bcd46007-2b6f-41b6-8d5d-22225014821c_B.pdf
- Tamaño:
- 579.41 KB
- Formato:
- Adobe Portable Document Format